首页> 外文期刊>Medicine. >Isolated skeletal muscle recurrence of an originally nodal diffuse large B cell lymphoma: A case report and review of the literature
【24h】

Isolated skeletal muscle recurrence of an originally nodal diffuse large B cell lymphoma: A case report and review of the literature

机译:原发性淋巴结弥漫性大B细胞淋巴瘤的孤立性骨骼肌复发:一例病例报告并文献复习

获取原文
           

摘要

Rationale: Diffuse large B cell lymphoma (DLBCL) is a malignancy of the B cells with extranodal primary involvement being estimated at 30% to 40% of cases. Primary skeletal muscle presentation of DLBCL is extremely rare, with an estimated incidence of about 0.5% of extranodal lymphomas, presenting mostly in the lower extremities. The possible mechanisms of muscle involvement of DLBCL include primary extranodal disease, extension from adjacent organs (such as lymph nodes) or disseminated disease. Patient concerns: We report a case of a 70-year-old woman with an advanced initially nodal DLBCL, treated with R-CHOP, that presented with an enlargement of her left thigh and restricted mobility 3 months after completion of chemotherapy. Imaging studies were performed, which showed possible infiltration of the muscles of the left thigh, without any nodal disease present. Diagnoses: Muscle biopsy documented the recurrence of the lymphoma at the left thigh. Interventions: The patient started second-line treatment with gemcitabine and vinorelbine. Outcomes: A partial response was achieved after the first cycle. Lessons: The remarkable element lies in the reappearance of the lymphoma at the left thigh muscles, with no radiographic or clinical evidence of involvement of lymph nodes, despite the extensive lymph node disease at initial presentation. The further management of such recurrences remains to be clarified, as the odd biological behavior of the malignant cells dictates a special handling of the disease.
机译:理由:弥漫性大B细胞淋巴瘤(DLBCL)是B细胞的恶性肿瘤,其结外原发灶估计占病例的30%至40%。 DLBCL的主要骨骼肌表现极为罕见,估计约有0.5%的结外淋巴瘤发生,主要表现在下肢。 DLBCL肌肉受累的可能机制包括原发性结外病,从邻近器官延伸(例如淋巴结)或播散性疾病。患者关注:我们报告了一名70岁的女性,该患者最初接受了R-CHOP治疗的晚期结节性DLBCL,在化疗完成3个月后,左大腿增大,活动受限。进行了影像学研究,结果表明左大腿肌肉可能浸润,没有任何淋巴结病。诊断:肌肉活检证实左大腿淋巴瘤复发。干预措施:患者开始用吉西他滨和长春瑞滨进行二线治疗。结果:第一个周期后获得部分反应。经验教训:尽管最初表现为广泛的淋巴结病,但值得注意的是,左大腿肌肉再次出现淋巴瘤,没有影像学或临床证据表明淋巴结受累。由于恶性细胞的奇异生物学行为决定了对该疾病的特殊处理,因此此类复发的进一步处理尚待阐明。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号